Argelia Esperanza Rojas-Mayorquín

Argelia Esperanza Rojas-Mayorquín

Auto-generated profile, based on publicly available information

Argelia Esperanza Rojas-Mayorquín

Departamento de Ciencias Ambientales, Instituto de Neurociencias, CUCBA, Universidad de Guadalajara, Guadalajara, JAL, Mexico

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
JGJosé de Jesús Guerrero-García
José de Jesús Guerrero-García
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
AMAna Laura Márquez-Aguirre
Ana Laura Márquez-Aguirre
ARArgelia Esperanza Rojas-Mayorquín
Argelia Esperanza Rojas-Mayorquín
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
Multiple Sclerosis (MS) is an autoimmune disorder of the Central Nervous System that has been associated with several environmental factors, such as diet and obesity. The possible link between MS and obesity has become more interesting in recent years since the discovery of the remarkable properties of adipose tissue. Once MS is initiated, obesity can contribute to increased disease severity by negatively influencing disease progress and treatment response, but, also, obesity in early life is highly relevant as a susceptibility factor and causally related risk for late MS development. The aim of this review was to discuss recent evidence about the link between obesity, as a chronic inflammatory state, and the pathogenesis of MS as a chronic autoimmune and inflammatory disease. First, we describe the main cells involved in MS pathogenesis, both from neural tissue and from the immune system, and including a new participant, the adipocyte, focusing on their roles in MS. Second, we concentrate on the role of several adipokines that are able to participate in the mediation of the immune response in MS and on the possible cross talk between the latter. Finally, we explore recent therapy that involves the transplantation of adipocyte precursor cells for the treatment of MS.